Special Sessions On COVID-19
These virtual, interactive sessions require that you register in advance for the meeting.
Check this page for updated information on speakers and session descriptions!
|Tuesday, May 12||1:30-5:30 PM CDT|
|Wednesday, May 13||12:00–1:00 PM CDT|
COVID-19 Keynote Address
|Wednesday, May 13||1:00–2:00 PM CDT|
Special Session on COVID-19: Diagnostics
Content Experts for Online Q&A
|Thursday, May 14||12:00–1:00 PM CDT|
Special Session on COVID-19: Therapeutics
Content Experts for Q&A
|11:00 AM–12:00 PM CDT|
Special Session on COVID-19: Rebuilding After the COVID-19 Shutdown: Choices for the Healthcare System
"From Katrina to COVID-19: Emergency Care for the Underserved During Times of Crisis"
Paul G Auwaerter, MD, MBA, FIDSA
Paul G Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.
He serves as the Executive Director of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center producing the Johns Hopkins ABX (Antibiotic), JH HIV, JH Osler, JH Psychiatry and JH Diabetes Guides. Dr. Auwaerter serves as Editor-in-Chief of the ABX Guide that over the last 20 years has grown to be a standard reference for ID-related clinical decision support and rationale antimicrobial management. Dr. Auwaerter’s research and clinical interests include improving the diagnosis and care for patients with Lyme disease and other tick-borne infections as well as work in surgical infections, Epstein-Barr virus, respiratory diseases and antibiotic resistance. He is a Past President of the Infectious Diseases Society of America (IDSA), the largest professional society worldwide related to infectious diseases.
Colin Greineder, MD, PhD
Dr. Greineder attended the Yale School of Medicine and completed Emergency Medicine residency at the University of Michigan. After a year working in the community, he returned to academia to pursue a PhD in Pharmacology and post-doctoral fellowship at the University of Pennsylvania. Throughout this long period of scientific training, Dr. Greineder continued to work as an attending in a variety of academic and community ERs, including UPenn, Thomas Jefferson, Geisinger Medical Center, and the Crozer-Keystone Health System. He was awarded a K08 Career Development award from the NHLBI and returned to Michigan Medicine in 2018 as a tenure track faculty in Emergency Medicine and Pharmacology. Dr. Greineder’s laboratory focuses on development of novel pharmacologic therapies for the treatment of emergent ischemic, thrombotic, and inflammatory disorders. The primary focus is affinity ligand delivery of biotherapeutics to endothelial cells as a means of restoring their homeostatic functions and elucidating their role in disease pathogenesis. Additional interests include pharmacokinetic modeling, coagulofibrinolytic changes in critical illness, and risk stratification and management of venous thromboembolism.
Sanjey Gupta, MD
Dr. Gupta is the Chairperson of Emergency Medicine at Southide Hospital/Northwell Health and is an Associate Professor of Emergency Medicine at Zucker School of Medicine at Hosftra/Northwell. He is a graduate of New York Medical College and completed his residency at North Shore University Hospital. His academic interests include Wilderness Medicine, ED Operations, and faculty development.
Dennis Hsieh, MD, JD
Dennis Hsieh is an assistant professor of emergency medicine and the Director for Social Medicine and Community Health for Harbor-UCLA Medical Center, which is part of the Los Angeles County Department of Health Services. He focuses on access to care and the social determinants of health (SDOH), including SDOH screening and interventions across clinical settings, hospital-based violence intervention programs, medical-legal community partnerships (MLCPs) and re-entry from jail. He is the former medical director the Whole Person Care Jail re-entry program. Dennis has a special interest in addressing SDOH such as violence, food, housing, and financial strain to improve health. He co-founded the hospital-based violence intervention program at Harbor-UCLA and is now co-leading the development of a trauma recovery center at Harbor-UCLA. Dennis is a founding member of the UCLA Department of Emergency Medicine’s Section on International and Domestic Health Equity (IdHEAL, www.idheal.org); ACEP’s Social Emergency Medicine Section and is the section’s chair elect; and SAEM’s Social Emergency Medicine and Population Health Interest Group. Dennis earned his A.B. in Biochemical Sciences from Harvard, J.D. from Yale and M.D. from UC San Francisco.
James F. Holmes, MD, MPH
James F. Holmes, MD, MPH is a Professor and Executive Vice Chair in the Department of Emergency Medicine at UC Davis School of Medicine. He earned his Doctorate of Medicine from the University of Alabama School of Medicine and his Master of Public Health from the University of California Berkeley School of Public Health. Dr. Holmes trained in Emergency Medicine at the University of California, Davis Medical Center, where he also served as Chief Resident.
His research is focused on the initial evaluation and treatment of injured patients with a particular emphasis on injured children. He has had funding for his research from a variety of federal agencies including the CDC, EMSC and the NIH. He has additionally devoted much of his career to training junior investigators. He is the Director of both the UC Davis Clinical and Translational Science Center’s KL2 Research Training Program and the UC Davis Emergency Medicine Research Fellowship. Finally, he has been very involved in the Society for Academic Emergency Medicine (SAEM) and will begin his term as SAEM President at SAEM20.
Namita Jayaprakash, MD, BsH BAO, MRCEM
Dr. Jayaprakash is am EM-Intensivist at Henry Ford Hospital in Detroit, MI and Clinical Assistant Professor of Emergency Medicine at Wayne State University. She splits her clinical time between the emergency department and medical ICU and is a member of the early intervention team at Henry Ford Hospital, seeing critical care consults in the ED. Her primary areas of interest are in early interventions in critical illness, in particular sepsis. Detroit was hit hard during the COVID-19 pandemic and thus she found herself in a position taking care of COVID-19 patients right from the ED all the way through their ICU course.
|Patrick Maher, MD|
I obtained my undergraduate degree at the University of Georgia and my medical degree from Georgetown University, in Washington, D.C. For residency, I was selected as part of the inaugural class in Emergency Medicine at the University of Washington, in Seattle, where I also completed my fellowship in Critical Care Medicine in 2017. After fellowship, I relocated to New York, where I have been part of the Research and Critical Care divisions of the Department of Emergency Medicine at the Icahn School of Medicine at Mount Sinai. In this time, I have also completed a Master of Science degree in Biostatistics from Columbia University. I was funded by the NIH as a T32-researcher investigating hemorrhage and coagulopathy in the ED and ICU settings. In addition to clinical work as an attending at the Mount Sinai Hospital Emergency Department, I also am the first faculty member hired with an EM background to work in our Medical ICU at Mount Sinai Hospital.
Lisa L. Maragakis, MD, MPH
Lisa Maragakis is an Associate Professor of Medicine at The Johns Hopkins University School of Medicine where she received her medical degree and post-doctoral Infectious Diseases training and a master’s degree in public health from The Johns Hopkins University Bloomberg School of Public Health. She serves as Senior Director for Healthcare Epidemiology and Infection Prevention for the Johns Hopkins Health System in Baltimore, Maryland. Dr. Maragakis is the Executive Director of the Biocontainment Unit at the Johns Hopkins Hospital. She serves as Co-Chair of the Healthcare Infection Control Practices Advisory Committee (HICPAC) for the Centers for Disease Control and Prevention, and as Co-Chair for the 2020 update of the SHEA-IDSA Compendium of Strategies to Prevent Healthcare Associated Infections. Her research interests integrate infection prevention, human factors engineering, implementation science, and mathematical modeling approaches to develop new interventions to prevent the transmission of high-consequence pathogens in healthcare settings.
David Persing, MD, PhD
David (Dave) Persing, MD, Ph.D., is Chief Medical and Technology Officer at Cepheid, and in 2017 was appointed Chief Scientific Officer (CSO) for the Danaher Diagnostics Platform. He has spent most of his 25-year career in biomarker discovery, translational medicine and innovation in the diagnostics space. As CSO, Danaher Diagnostics Platform, he has the responsibility for providing scientific, medical and strategic input to the Diagnostics' Operating Companies and Platform leadership. He also has the responsibility for development of new clinical processes, technologies or products that advance patient care, innovation and competitive position of the Danaher Diagnostics group of operating companies. Dave joined Cepheid in 2005 and has focused on the enablement of molecular diagnostic technology to meet global needs in infectious diseases and oncology. He conducted his scientific and medical training with Don Ganem and Nobel laureate Harold Varmus at the University of California, San Francisco. Since completing his residency training in clinical pathology at Yale University, he has held leadership roles in academia and industry starting in the early 1990s with the design, implementation, and operation of the first PCR reference laboratory at the Mayo Clinic. His interest in the democratization of molecular diagnostic methods has been longstanding, starting in 1993 with his publication of the first widely adopted textbook to include PCR protocols and guidelines for laboratory operations. He has published over 300 peer-reviewed articles and reviews, including multiple articles in the New England Journal of Medicine, Science, and PNAS, and has served as Editor in Chief for five highly regarded textbooks, the most recent of which was published in 2016. To maintain a connection with the latest trends in translational medicine, Dave also serves as Consulting Professor of Pathology at Stanford University School of Medicine. He obtained his MD and PhD degrees from UCSF in 1988.
Joshua M. Sharfstein, MD
Dr. Joshua M. Sharfstein is Vice Dean for Public Health Practice and Community Engagement and Professor of the Practice in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health.
Previously, Dr. Sharfstein served as Secretary of the Maryland Department of Health and Mental Hygiene, as Principal Deputy Commissioner of the U.S. Food and Drug Administration, and as Commissioner of Health for Baltimore City. He is an elected member of the National Academy of Medicine and the National Academy of Public Administration.
He is the author of the Public Health Crisis Survival Guide: Leadership and Management in Trying Times (2018). He is also the co-author of the book, The Opioid Epidemic: What Everyone Needs to Know (2019), both from Oxford University Press.
Jean Sun Scofi, MD
Dr. Jean Sun Scofi is the Assistant Medical Director of the Department of Emergency Medicine at Yale New Haven Hospital (YNHH) and an Executive MBA candidate at the Yale School of Management. Dr. Scofi is a member of the YNHH Emergency Medicine COVID-19 Task Force and editor of the YNHH Emergency Department Operational Handbook for COVID-19. She also serves as a Research Fellow for the ACEP Emergency Quality Network (E-QUAL) and Co-Chair of the Didactics Subcommittee for the SAEM20 Annual Meeting. Her research interests include quality improvement, physician audit and feedback, administrative education, and healthcare operations.
Leana S. Wen, MD, MSc
Dr. Leana Wen is a visiting professor of health policy and management at the George Washington University Milken Institute School of Public Health, where she is also the distinguished fellow of the Fitzhugh Mullan Institute for Health Workforce Equity. Previously, she served as the Commissioner of Health for the City of Baltimore and as the President/CEO of Planned Parenthood. In 2019, Dr. Wen was named one of TIME magazine’s 100 Most Influential People and as Modern Healthcare’s 50 Most Influential Clinician-Executives.
Dr. Wen earned her medical degree from Washington University School of Medicine and her master’s degrees at the University of Oxford, where she was a Rhodes Scholar. She completed her residency training in emergency medicine at Brigham & Women’s Hospital and Massachusetts General Hospital. The author of dozens of scientific articles, she has been an op-ed contributor for the Washington Post, National Public Radio, and Baltimore Sun, and is regularly featured on CNN, MSNBC, NPR, BBC, and PBS